Independent prognosis and survival analysis revealed important differential genes, including RACGAP1, TCF7L2, IRF7, DMD, and JUN, which can be used as effective biomarkers for screening and characterizing patients with BRCA and COVID-19 at all stages. This evidence concerns the gene RACGAP1 and COVID-19.